crosslinking

PiXL appears promising for low myopiaThe use of epi-on photorefractive intrastromal cross linking reduced myopia by about 0.25 D in a small study; In a high-oxygen group, the effect averaged 1.25 D.
Toward emmetropia: More advances, more improvementsAdvances in treatments for keratoconus and presbyopia in 2016 continued to move patients toward emmetropia.
Crosslinking showing potential for refractive correction
Crosslinking showing potential for refractive correctionPhotorefractive intrastromal cross-linking is being developed for non-invasive correction of low refractive errors.
Collagen corneal cross-linking for keratoconusThe recently approved procedure will help many with this progressive disease
Clinical implications of corneal cross-linkingNow that we have CXL , it is imperative for clinicians to incorporate new technologies that can help us achieve disease detection at the earliest clinical stage prior to onset of visual symptoms.
When is crosslinking appropriate?Though the main benefit of collagen corneal crosslinking is to stop progression of keratoconus, it is not the sole benefit, said Theo Seiler, MD, PhD (Greece) here during Cornea Day at ASCRS 2016.
Photoactivation holds promise for keratitis treatment
Photoactivation holds promise for keratitis treatmentThe same photoactivation process used in collagen cross-linking for keratoconus can kill bacteria without the need for the oxygen responsible for the biomechanical effects, potentially pointing toward better treatments for keratitis, according to Olivier Richoz, MD, PhD.
Trends in U.S. refractive surgery: 2015 ISRS surveyThe 2015 International Society of Refractive Surgery survey, the twentieth such survey and the seventh year published online, presents new findings about surgeons’ preferences in corneal and lens-based surgeries, premium intraocular lenses (IOLs), and femtosecond cataract surgery.
New study finds limits of keratometry in keratoconusReproducibility of keratometry is better for early keratoconus than for advanced keratoconus, a new study showed. The study could help clinicians decide when to use corneal cross-linking in their efforts to stop the progression of the disease, wrote Tom H. Flynn, PhD, and his colleagues from the Corneal Service, Moorfields Eye Hospital, St. George’s Hospital, London. They published their finding in the British Journal of Ophthalmology.
Improving LASIK outcomes: Addition of CXL for corneal stabilityAchieving super-vision after LASIK may rest on the addition of corneal collagen crosslinking around the time of surgery.